Lake Region Medical Joins with Greatbatch
|
By HospiMedica International staff writers Posted on 07 Sep 2015 |
Medical technology company Greatbatch (Frisco, TX, USA) will buy privately owned Lake Region Medical (Wilmington, MA, USA), in a deal valued at about USD 1.73 billion in cash and stock.
Starting out as a fishing-lure company in 1947, Lake Region Medical found success in the 1960’s when the family-run operation began manufacturing tightly coiled wires for some of the earliest pacemakers made by Medtronic (Dublin, Ireland); it went on to develop offerings in electrophysiology, vascular access, urology, oncology, orthopedics, laparoscopy, arthroscopy, and other fields. In March 2014, the company was acquired for USD 390 million by Accellent, a large supplier and strategic partner to the medical device industry, which changed its brand name to Lake Region Medical shortly after.
Greatbatch was founded by Wilson Greatbatch, who helped invent the first implantable pacemaker in 1961 and licensed it to Medtronic, whose own co-founder, Earl Bakken, had invented the first transistorized, wearable pacemaker four years earlier. Greatbatch went on to invent a lithium-iodine battery that greatly extended the life of pacemakers. The company now develops critical device technologies for cardiac, neuromodulation, vascular, and orthopedic markets, as well as batteries for high-end niche applications in the portable medical, energy, military, and environmental markets.
While the deal is slated to create one of the largest original equipment manufacturer (OEM) outsourcing companies for medical technology in the world, it will still have a share of only about 10%–12% of the highly fragmented industry. The combined entity will sell OEM parts and manufacturing solutions to major medical device companies for cardiac-rhythm management, neuromodulation, and vascular, orthopedic and surgical therapies, with operations in the United States, Latin America, Europe, and the Asia-Pacific region.
"The combination of Greatbatch and Lake Region Medical brings together two highly complementary organizations that can provide a new level of industry leading capabilities and services to OEM customers while building value for shareholders," said Thomas J. Hook, president and CEO of Greatbatch. “Through this transformative deal, we are going to be at the forefront of innovating technologies and products that help change the face of healthcare.”
“I am very proud of the Lake Region Medical team and what they have accomplished over many years,” said Donald Spence, CEO of Lake Region Medical. “I am confident the combination of Lake Region Medical and Greatbatch will form an even stronger entity with unmatched technology and manufacturing capabilities.”
Related Links:
Greatbatch
Lake Region Medical
Starting out as a fishing-lure company in 1947, Lake Region Medical found success in the 1960’s when the family-run operation began manufacturing tightly coiled wires for some of the earliest pacemakers made by Medtronic (Dublin, Ireland); it went on to develop offerings in electrophysiology, vascular access, urology, oncology, orthopedics, laparoscopy, arthroscopy, and other fields. In March 2014, the company was acquired for USD 390 million by Accellent, a large supplier and strategic partner to the medical device industry, which changed its brand name to Lake Region Medical shortly after.
Greatbatch was founded by Wilson Greatbatch, who helped invent the first implantable pacemaker in 1961 and licensed it to Medtronic, whose own co-founder, Earl Bakken, had invented the first transistorized, wearable pacemaker four years earlier. Greatbatch went on to invent a lithium-iodine battery that greatly extended the life of pacemakers. The company now develops critical device technologies for cardiac, neuromodulation, vascular, and orthopedic markets, as well as batteries for high-end niche applications in the portable medical, energy, military, and environmental markets.
While the deal is slated to create one of the largest original equipment manufacturer (OEM) outsourcing companies for medical technology in the world, it will still have a share of only about 10%–12% of the highly fragmented industry. The combined entity will sell OEM parts and manufacturing solutions to major medical device companies for cardiac-rhythm management, neuromodulation, and vascular, orthopedic and surgical therapies, with operations in the United States, Latin America, Europe, and the Asia-Pacific region.
"The combination of Greatbatch and Lake Region Medical brings together two highly complementary organizations that can provide a new level of industry leading capabilities and services to OEM customers while building value for shareholders," said Thomas J. Hook, president and CEO of Greatbatch. “Through this transformative deal, we are going to be at the forefront of innovating technologies and products that help change the face of healthcare.”
“I am very proud of the Lake Region Medical team and what they have accomplished over many years,” said Donald Spence, CEO of Lake Region Medical. “I am confident the combination of Lake Region Medical and Greatbatch will form an even stronger entity with unmatched technology and manufacturing capabilities.”
Related Links:
Greatbatch
Lake Region Medical
Latest Business News
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
- WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
- Interoperability Push Fuels Surge in Healthcare IT Market
- Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
- B. Braun Acquires Digital Microsurgery Company True Digital Surgery
- CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more







